Brian McClune

机构：University of Utah · ORCID：0000-0003-0007-4192

发表论文 135 篇 · 总被引 3184 次 · h-index 23

代表论文

• Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation (2023 · Blood · 被引 13)
• A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT (2026 · Blood · 被引 9)
• Access barriers to hematopoietic stem cell transplantation and CAR T-cells in US (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 5)
• The past, present, and future of myeloma staging and risk prognostication (2025 · The Oncologist · 被引 4)
• Remission of TP53 -Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33) (2025 · JCO Precision Oncology · 被引 3)
• Patient Preferences on Clinical Decision Making in Multiple Myeloma (2025 · JCO Oncology Practice · 被引 3)